Cargando…
Noncoding RNAs in Drug Resistance of Gastrointestinal Stromal Tumor
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor in the gastrointestinal tracts and a model for the targeted therapy of solid tumors because of the oncogenic driver mutations in KIT and PDGDRA genes, which could be effectively inhibited by the very first targeted agent, ima...
Autores principales: | Li, Jiehan, Guo, Shuning, Sun, Zhenqiang, Fu, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841737/ https://www.ncbi.nlm.nih.gov/pubmed/35174150 http://dx.doi.org/10.3389/fcell.2022.808591 |
Ejemplares similares
-
Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer
por: Wei, Ling, et al.
Publicado: (2023) -
The role of long noncoding RNAs in therapeutic resistance in cervical cancer
por: Zhou, Meimei, et al.
Publicado: (2022) -
Identification of New Tumor-Related Gene Mutations in Chinese Gastrointestinal Stromal Tumors
por: Feng, Yuyang, et al.
Publicado: (2021) -
Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer
por: Wei, Ling, et al.
Publicado: (2021) -
Emerging Roles of Long Noncoding RNAs in Immuno-Oncology
por: Wang, Xin, et al.
Publicado: (2021)